How long does it take for Platinib (Pujihua) capsules to be absorbed by the body after taking them?
Pralsetinib is an oral selective RET tyrosine kinase inhibitor mainly used for treatment RETfusion-positive non-small cell lung cancer (NSCLC), thyroid cancer and other RET driven tumors. As a capsule preparation, Platinib is absorbed through the gastrointestinal tract and enters the blood circulation to achieve systemic effects. Understanding its absorption characteristics can help to rationally arrange medication time and dietary intervention to improve efficacy.
Research shows that oral platinib capsules can reach peak plasma concentration (C_max) about 2 to 4 hours after taking it, indicating that the drug is absorbed quickly and has good bioavailability. Taking it before meals or on an empty stomach has little effect on absorption, but high-fat meals may slightly delay absorption. Mastering the absorption time has reference value for clinical efficacy evaluation and adverse reaction monitoring.

The absorption of platinib is affected by many factors, including gastrointestinal function, drug dosage, and accompanying food. Delayed gastric emptying, indigestion, or concomitant use of certain antacid medications may affect the rate of drug dissolution and absorption. In addition, patients with abnormal liver and kidney function may have delayed peak plasma concentration or prolonged duration due to metabolic changes. Doctors usually make personalized medication recommendations based on the patient's condition.
In clinical use, Platinib capsules are recommended to be taken orally once a day on an empty stomach or with meals as directed by your doctor to ensure stable blood concentration. Patients reach peak absorption within 2-4 hours after taking the drug. During this period, potential adverse reactions, such as mild nausea and decreased appetite, can be observed. In order to optimize efficacy and safety, arbitrary adjustment of medication time or dosage should be avoided, and blood drug levels and tumor indicators should be monitored with regular follow-up to ensure maximum treatment effect.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)